BBC1501
/ BenoBio
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
July 08, 2025
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: Benobio Co., Ltd. | Not yet recruiting ➔ Recruiting | Trial completion date: Oct 2025 ➔ Mar 2026 | Trial primary completion date: May 2025 ➔ Dec 2025
Enrollment open • Trial completion date • Trial primary completion date • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration
June 17, 2024
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Benobio Co., Ltd. | Trial completion date: Oct 2024 ➔ Oct 2025 | Trial primary completion date: May 2024 ➔ May 2025
Trial completion date • Trial primary completion date • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration
December 15, 2023
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Benobio Co., Ltd. | Trial completion date: Apr 2024 ➔ Oct 2024 | Trial primary completion date: Jan 2024 ➔ May 2024
Trial completion date • Trial primary completion date • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration
October 12, 2023
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Benobio Co., Ltd. | Initiation date: Apr 2023 ➔ Nov 2023
Trial initiation date • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration
April 07, 2023
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Benobio Co., Ltd.
New P1 trial • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration
1 to 5
Of
5
Go to page
1